Is Jabil a good company?
Jabil Inc. is widely recognized as a premier, Fortune 500 manufacturing solutions provider and one of the largest electronic manufacturing services companies in the world. The company serves as an essential, behind-the-scenes manufacturing partner for some of the world's most dominant technology, healthcare, and automotive brands, notably including Apple. Jabil boasts extraordinary engineering capabilities, advanced supply chain analytics, and a massive global footprint that allows it to scale production rapidly for its elite clientele. Employees often highlight the dynamic, fast-paced work environment and opportunities to work on cutting-edge hardware products across diverse industries, from medical devices to 5G telecommunications infrastructure. Financially, the company has demonstrated disciplined capital allocation, steady revenue growth, and strong free cash flow generation, making it a highly respected and essential pillar of the global hardware supply chain.
Related FAQs
Samsung and LG are major competitors in the global consumer electronics market, but they are "connected" through industry-wide collaboration initiatives.
Yes, Jabil Inc. officially announced plans to wind down operations and permanently close its manufacturing facility located in Clinton, Massachusetts, by December 2026.
Jerónimo Martins is a major international food distribution and retail conglomerate based in Portugal, operating market-leading supermarket and discount chains across Europe and Latin America.
Executive compensation for the chief executive leadership guiding Jacobs Solutions Inc. (a premier global technical, professional, and construction engineering services enterprise) reflects corporate governance benchmarks.
The corporate brand name Jabil does not function as a standard multi-word initialism with individual dictionary definitions for each letter, but rather originates from the personal names of its founders.
Executive compensation for Gilberto Tomazoni, serving as the Global Chief Executive Officer of JBS S.A. (the world's largest meat processing and protein enterprise), reflects major international food industry benchmarks.
Jabil Inc. anticipates a strong future growth outlook supported by its global leadership in advanced manufacturing, supply chain solutions, and customized technological design services.
Jason Honeyman, serving as the Chief Executive Officer and Executive Director of Bellway p.l.c.—a major residential housebuilding enterprise in the United Kingdom—commands a comprehensive executive remuneration package.
Jabil Inc. operates as a premier global manufacturing services and solutions provider, delivering advanced design, engineering, and supply chain manufacturing products for diverse industries.
Pronouncing JBT Marel, the food processing technology firm, involves combining an initialism with a brand name. For "JBT," you say the letters individually: "JAY-BEE-TEE." For "Marel," you break it into two syllables: "MA-rel.
James Mwangi, serving as the prominent Group Chief Executive Officer and Managing Director of Equity Group Holdings, receives a comprehensive executive compensation package running into millions of shillings annually.
Jabil Inc., a major global manufacturing services and technological solutions enterprise providing comprehensive design, production, and supply chain management to diverse industries, has its primary corporate headquarters located in St.
Jabil Inc., a major global manufacturing services and supply chain enterprise, partners with Amazon to manufacture, assemble, and test a wide variety of Amazon consumer hardware devices.
Yes, Jabil and JBL refer to the exact same corporate entity within the context of financial markets and investing. "JBL" is simply the official, three-letter stock ticker symbol under which Jabil Inc. trades on the New York Stock Exchange.
Senior directors managing specialized departments—such as commercial data enablement, regulatory affairs, clinical development, or pharmacology—at Jazz Pharmaceuticals earn elite executive compensation packages reflecting biopharmaceutical industry s...